I-Mab, BCT to work on Arginine Depletion Therapy and Biomarker Study

Drug Discovery |  News | 0 Comment | 04 Feb, 2019

I-Mab Biopharma (I-Mab), a China-based clinical stage biopharmaceutical company exclusively focused on the developm...Read more

FDA expands Lilly's ALIMTA Label

Drug Discovery |  News | 0 Comment | 01 Feb, 2019

Eli Lilly and Companyhas announced that USFDA has granted approval for a new indication for ALIMTA® (pemetrexed...Read more

Neurocrine Biosciences collaborates with Voyager Therapeutics

Drug Discovery |  News | 0 Comment | 31 Jan, 2019

Neurocrine Biosciences and Voyager Therapeutics has announced the formation of a strategic collaboration focused on the ...Read more

Pfizer and Lilly announce top-line results of Tanezumab

Drug Discovery |  News | 0 Comment | 31 Jan, 2019

Pfizer and Eli Lilly have announced positive top-line results from a Phase 3 study evaluating tanezumab 2.5 mg or 5 mg i...Read more

J&J announces USFDA approval of IMBRUVICA

Drug Discovery |  News | 0 Comment | 29 Jan, 2019

The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the U.S. Food and Drug Administration (FDA) ...Read more

Basilea announces collaboration with Roche

Drug Discovery |  News | 0 Comment | 25 Jan, 2019

Commercial stage biopharma company, Basilea Pharmaceutica has announced that it entered into a collaboration with Roche ...Read more

Wren Therapeutics completes £18M Series A Financing

Drug Discovery |  News | 0 Comment | 23 Jan, 2019

UK based biopharma company, Wren Therapeutics focused on drug discovery and development for protein misfolding diseases ...Read more

AbbVie provides update on Phase 3 Study of IMBRUVICA

Drug Discovery |  News | 0 Comment | 22 Jan, 2019

AbbVie, a research-based global biopharmaceutical company has announced an update on the Phase 3 RESOLVE trial (PCYC-113...Read more

Everest Medicines signs new deal targeting drug resistance

Drug Discovery |  News | 0 Comment | 14 Jan, 2019

Spero Therapeutics, Inc., a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and ...Read more

Janssen submits application to EMA seeking approval of STELARA

Drug Discovery |  News | 0 Comment | 11 Jan, 2019

The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a Group Type II Variation ...Read more

Denali Therapeutics announces Phase 1B Study of DNL747

Drug Discovery |  News | 0 Comment | 11 Jan, 2019

Denali Therapeutics Inc., a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurode...Read more

Japan approves Amgen's osteoporosis drug

Drug Discovery |  News | 0 Comment | 10 Jan, 2019

Amgen and UCB  announced that the Japanese Ministry of Health, Labor and Welfare has granted a marketing authorizat...Read more

Daiichi Sankyo receives regulatory approval for hypertension tablets

Drug Discovery |  News | 0 Comment | 10 Jan, 2019

Exelixis, Inc. has announced that its partner Daiichi Sankyo Company, Limited received approval from the Japanese Minist...Read more

Cellular Biomedicine Initiates clinical trial in anti-BCMA CAR-T therapy

Drug Discovery |  News | 0 Comment | 09 Jan, 2019

Cellular Biomedicine Group Inc., a biopharmaceutical firm engaged in the development of immunotherapies for cancer and s...Read more

Oculis raises CHF 15.5 million

Drug Discovery |  News | 0 Comment | 08 Jan, 2019

Oculis SA, a clinical-stage biopharmaceutical company developing next-generation topical ophthalmic treatments recently ...Read more

AbbVie and Tizona Therapeutics announce strategic collaboration

Drug Discovery |  News | 0 Comment | 04 Jan, 2019

Biopharma company, AbbVie and Biotech company, Tizona Therapeutics has announced that they have entered into a global, s...Read more

Bristol-Myers Squibb’s Sprycel® tablets now approved for pediatric patients

Drug Discovery |  News | 0 Comment | 04 Jan, 2019

Bristol-Myers Squibb Company has announced the U.S. Food and Drug Administration (FDA) has expanded the indication for&n...Read more

AstraZeneca announces phase III trials for roxadustat

Drug Discovery |  News | 0 Comment | 03 Jan, 2019

AstraZeneca has announced that the Phase III OLYMPUS and ROCKIES trials for roxadustat each met their primary efficacy e...Read more